Fact-checked by Grok 2 weeks ago

DNA synthesis

DNA synthesis is the process by which deoxyribonucleic acid (DNA), the molecule that carries genetic instructions in living organisms, is produced to duplicate genetic information or create custom sequences. In biological contexts, it primarily refers to DNA replication, a fundamental mechanism occurring during the S phase of the cell cycle that ensures each daughter cell receives an identical copy of the genome before division. This semi-conservative process involves unwinding the double helix and using each strand as a template to synthesize complementary new strands, resulting in two complete DNA molecules from one. Beyond natural replication, DNA synthesis also encompasses artificial methods in biotechnology, where short oligonucleotides are chemically assembled into longer DNA constructs for applications in synthetic biology and gene engineering. The biological replication of DNA requires four key components: nucleotide substrates in the form of deoxyribonucleoside triphosphates (dNTPs), a single-stranded , a short or DNA primer to initiate synthesis, and a suite of enzymes within the complex. Synthesis proceeds bidirectionally from origins of replication, forming replication forks where the leading strand is synthesized continuously in the 5' to 3' direction, while the lagging strand is produced discontinuously as short that are later joined by . Central to this process is , which catalyzes the addition of complementary to the template—adenine (A) pairs with thymine (T), and guanine (G) with cytosine (C)—while incorporating proofreading mechanisms to achieve an error rate as low as 1 in 10^7 base pairs. Other essential enzymes include , which unwinds the DNA ; , which synthesizes the RNA primers; and , which relieves torsional stress ahead of the fork. This highly coordinated replication, taking about 8 hours in human cells to copy approximately 6 billion base pairs, is crucial for growth, repair, and the faithful transmission of genetic material across generations. In laboratory settings, chemical DNA synthesis enables the de novo creation of DNA without biological templates, revolutionizing fields like and . The dominant method, solid-phase phosphoramidite chemistry, involves a cyclic four-step process—deprotection, coupling of protected phosphoramidites, capping of unreacted chains, and oxidation—repeated on a solid support to build up to 100-200 long with error rates below 0.5%. These short synthons are then assembled into larger s or circuits using techniques such as cycling assembly (PCA) or , which exploit overlapping sequences and enzymatic to construct double-stranded DNA up to several kilobases. Advances in this technology, including microarray-based parallel synthesis, have drastically reduced costs to as low as $0.0001 per base and enabled high-throughput production, facilitating innovations like custom synthesis for therapeutics, , and . Despite challenges like sequence-dependent errors and scalability for very long DNA, ongoing improvements in fidelity and automation continue to bridge the gap between reading (sequencing) and writing (synthesis) genomes.

Natural Mechanisms of DNA Synthesis

DNA Replication

DNA replication is a semi-conservative process in which each strand of the parental DNA double helix serves as a template for the synthesis of a new complementary strand, ensuring accurate duplication of the during the . This model was proposed by and in 1953 based on the structure of the DNA double helix. It was experimentally confirmed in 1958 by and Franklin Stahl through density-gradient centrifugation experiments using isotopically labeled DNA in , demonstrating that after one round of replication, the DNA molecules had an intermediate density, and after two rounds, they separated into hybrid and light forms. In prokaryotes like E. coli, replication initiates at a single origin of replication, oriC, where the DnaA protein binds to specific sequences and recruits the DnaB helicase (in complex with DnaC) to unwind the double helix by breaking hydrogen bonds, forming a replication bubble. Primase (DnaG) then synthesizes short RNA primers complementary to the single-stranded DNA templates, enabling DNA polymerase III holoenzyme—the primary replicative polymerase—to begin elongation in the 5' to 3' direction. During elongation, synthesis occurs continuously on the leading strand, while the lagging strand is synthesized discontinuously as short Okazaki fragments (typically 1000–2000 nucleotides long), each requiring a new RNA primer. DNA polymerase I removes the RNA primers using its 5' to 3' exonuclease activity and replaces them with DNA via its polymerase activity, while DNA ligase seals the resulting nicks by forming phosphodiester bonds. Termination occurs when replication forks meet at the terminus region, facilitated by the Tus protein binding to Ter sites to block helicase progression. The core polymerization reaction catalyzed by DNA polymerase is: \text{dNTP} + (\text{DNA})_n \rightarrow (\text{DNA})_{n+1} + \text{PP}_\text{i} where a deoxyribonucleoside triphosphate (dNTP) is added to the growing 3' end, releasing pyrophosphate (PPi). In eukaryotes, replication initiates at thousands of origins per chromosome (up to 100,000 across the human genome) to accommodate larger genomes, with origins activated in a cell cycle-timed manner influenced by chromatin structure, resulting in a slower replication rate of about 50 nucleotides per second compared to prokaryotes. The linear chromosomes pose an end-replication problem, where the lagging strand at telomeres cannot be fully completed by standard polymerases; this is addressed by telomerase, a reverse transcriptase that extends the 3' overhang using an RNA template, allowing subsequent priming and completion. Overall fidelity is maintained by the 3' to 5' exonuclease proofreading activity of replicative polymerases, which removes mismatched nucleotides, achieving an error rate of approximately 1 in 10^9 base pairs incorporated when combined with post-replication mismatch repair.

Reverse Transcription

Reverse transcription is the process by which DNA is synthesized from an RNA template, a discovery made independently by Howard Temin and in 1970 through their identification of an RNA-dependent in retroviruses, which challenged the prevailing that genetic information flows unidirectionally from DNA to . For this groundbreaking work, along with Renato Dulbecco's contributions to tumor , Temin and Baltimore shared the 1975 in Physiology or Medicine. The key enzyme, (RT), functions as an RNA-dependent that synthesizes (cDNA) strands using deoxyribonucleoside triphosphates (dNTPs) as substrates, and it also possesses intrinsic RNase H activity that degrades the strand within RNA-DNA hybrids to facilitate subsequent steps. In retroviruses, RT is packaged within the viral particle and initiates synthesis shortly after . The process begins with the priming of viral RNA by a host tRNA annealed to the primer binding site (PBS) near the 5' end, leading to the synthesis of a minus-strand DNA from the 3' end of the RNA template. RNase H activity partially degrades the RNA template, exposing a cytosine-rich segment of the minus-strand DNA that anneals to the complementary 3' end of the RNA via repeated regions (R) and unique sequences (US), enabling a strand transfer. Minus-strand synthesis then continues to the 5' end of the RNA, after which RNase H fully removes the remaining RNA, except for the polypurine tract (PPT), which serves as a primer for plus-strand DNA synthesis. A second strand transfer occurs using the terminal repeats (R-US), allowing completion of the double-stranded DNA product, which includes long terminal repeats (LTRs) at both ends and is subsequently integrated into the host genome as a provirus by the viral integrase. Reverse transcriptase exhibits lower fidelity compared to cellular DNA polymerases, lacking 3'→5' proofreading activity, with an error rate of approximately 1 in 10^4 nucleotides incorporated, contributing to high mutation rates in retroviruses that enable immune evasion and . In , reverse transcription plays a central role in the retroviral life cycle, such as in where the proviral DNA integrates and directs viral and replication. It also underlies the propagation of endogenous retroviruses (ERVs), ancient viral sequences comprising about 8% of the human genome that can influence gene regulation and evolution. Additionally, , a specialized ribonucleoprotein, employs a reverse transcriptase subunit (TERT) to extend telomeres using an internal template (TERC), maintaining chromosomal ends during in stem and cancer cells. The core reaction catalyzed by reverse transcriptase is represented as: \text{dNTP} + (\text{RNA})_m \rightarrow (\text{DNA})_n + \text{PP}_i where the enzyme incorporates deoxyribonucleotides opposite the RNA template without proofreading in most retroviral RTs.

DNA Repair Synthesis

DNA repair synthesis is a critical process in maintaining genomic integrity, involving the targeted polymerization of DNA to fill gaps created after the excision of damaged or erroneous segments. This localized synthesis occurs in several excision repair pathways, including base excision repair (BER), nucleotide excision repair (NER), and mismatch repair (MMR), where DNA polymerases incorporate deoxyribonucleotide triphosphates (dNTPs) in a 5' to 3' direction using the undamaged complementary strand as a template. Unlike full genome replication, repair synthesis is activated in response to specific lesions and typically involves short to moderate patch lengths, ensuring precise restoration without extensive chromosomal disruption. In BER, which addresses small, non-helix-distorting base lesions such as oxidative damage (e.g., ) or , the process begins with damage recognition by that excise the faulty base, creating an abasic (. AP endonuclease (APE1) then cleaves the phosphodiester backbone at this site, generating a single-nucleotide gap in short-patch BER (1 nt) or a longer gap in long-patch BER (2-10 nt). DNA polymerase β (Pol β) primarily fills short-patch gaps with high fidelity, lacking intrinsic but benefiting from low error rates (~10^{-5} per ), while Pol δ or ε handles longer patches in conjunction with flap endonuclease 1 (FEN1) to remove displaced flaps and DNA ligase to seal the nick. For example, oxidative base damage from is repaired via this pathway, preventing mutations that could lead to cellular dysfunction. NER targets bulky, helix-distorting adducts, such as UV-induced cyclobutane (e.g., dimers), excising a 24-32 oligonucleotide segment containing the lesion through coordinated action of proteins (XPA-XPG). The resulting gap is filled by Pol δ or ε, which incorporate with activity for high fidelity (error rates <10^{-6}), assisted by replication factor C (), proliferating cell nuclear antigen (), FEN1 for flap processing, and I for joining. This pathway is essential for removing UV-induced damage, with synthesis ensuring accurate templating to avoid photoproduct persistence. MMR corrects replication errors, such as base-base mismatches or small insertion/deletion loops, primarily in eukaryotes through recognition by MutSα (MSH2-MSH6) or MutSβ (MSH2-MSH3) complexes, followed by recruitment of MutLα (MLH1-PMS2). excises the erroneous strand up to 100-1000 in a PCNA- and RFC-dependent manner, creating a gap filled by Pol δ, which employs 3'→5' proofreading for exceptional (enhancing overall replication accuracy 100-1000-fold). FEN1 and complete the process, with this pathway integrating with replication forks to post-replicatively correct errors and suppress recombination between divergent sequences.

In Vitro Enzymatic DNA Synthesis

Polymerase Chain Reaction (PCR)

The polymerase chain reaction (PCR) is an in vitro technique for exponentially amplifying specific segments of DNA, revolutionizing molecular biology by enabling the production of large quantities of target DNA from minute starting amounts without relying on living cells. Invented by Kary Mullis in 1983 while working at Cetus Corporation, PCR was first described in a 1985 publication that demonstrated its application in amplifying beta-globin sequences for sickle cell anemia diagnosis. Mullis received the Nobel Prize in Chemistry in 1993 for this innovation, which facilitated molecular cloning and other genetic analyses previously limited by the need for bacterial propagation. The core components of a PCR reaction include template DNA containing the target sequence, two primers that flank the region to be amplified (typically 18-22 long), deoxynucleotide triphosphates (dNTPs) as building blocks, and a thermostable . The polymerase most commonly used is Taq, isolated from the thermophilic bacterium , which maintains activity at high temperatures and has an optimal extension temperature of around 72°C. These components are assembled in a and subjected to repeated thermal cycles in a thermocycler, mimicking the strand separation aspect of natural but in a controlled, artificial environment. Each PCR cycle consists of three main steps: denaturation at 94-98°C to separate the double-stranded DNA template into single strands, annealing at 50-65°C where primers hybridize to their complementary sequences on the template, and extension at 72°C where Taq polymerase synthesizes new DNA strands by adding dNTPs to the 3' ends of the primers. Typically, 20-40 cycles are performed, leading to exponential amplification where the number of target DNA copies approximately doubles with each cycle under ideal conditions, yielding N = N_0 \times 2^n after n cycles, or more generally N = N_0 \times (1 + E)^n with efficiency E approaching 1 for optimized reactions. PCR has broad applications, including preparing DNA inserts for into vectors, generating amplicons for , and forensic analysis such as short tandem repeat (STR) profiling to identify individuals from crime scene samples. Despite its utility, PCR can suffer from limitations like non-specific amplification due to primer misbinding at lower temperatures and formation of primer dimers, which compete with target amplification and produce extraneous products. These issues are often mitigated through optimization strategies, such as hot-start PCR, where the is initially inactivated (e.g., via antibodies or chemical modifications) and activated only during the first denaturation step to prevent premature activity. Taq polymerase lacks 3'→5' exonuclease proofreading activity, resulting in a fidelity of approximately 1 error per 10^4 to 10^5 nucleotides incorporated, which can introduce mutations during amplification of longer targets.

Reverse Transcription PCR (RT-PCR)

Reverse transcription polymerase chain reaction (RT-PCR) is a laboratory technique that combines reverse transcription of to (cDNA) with subsequent amplification, enabling the analysis of RNA templates such as (mRNA). Developed in the late 1980s, RT-PCR built upon the 1970 discovery of by Howard Temin and , which demonstrated RNA-templated DNA synthesis in retroviruses. The seminal demonstration of RT-PCR occurred in 1988, when Frohman et al. introduced a method to rapidly produce full-length cDNAs from rare transcripts using a single gene-specific primer, marking a key advancement for amplifying low-abundance RNAs. RT-PCR can be performed in two main formats: two-step or one-step protocols. In the two-step format, reverse transcription is conducted separately from amplification, allowing independent optimization of each stage and the use of flexible priming strategies; this approach generates a stable cDNA pool that can be stored and used for multiple downstream reactions. In contrast, the one-step format integrates reverse transcription and in a single reaction tube using gene-specific primers, reducing handling steps, minimizing risk, and simplifying high-throughput workflows, though it limits flexibility for multi-gene . Both formats typically employ retroviral-derived , such as Moloney (MMLV) reverse transcriptase, which exhibits RNA-dependent activity, alongside thermostable s like Taq for the amplification phase. The core process begins with cDNA synthesis from mRNA templates, initiated by using primers such as oligo(dT) to target the poly(A) tail, random hexamers for unbiased coverage across the , or gene-specific primers for targeted transcripts. This step converts single-stranded into double-stranded cDNA, which then serves as the for standard amplification using gene-specific primers, dNTPs, and a thermostable to generate exponential copies of the target sequence. Key applications of RT-PCR include quantitative real-time reverse transcription PCR (RT-qPCR), which monitors amplification in real time to quantify levels. RT-qPCR employs fluorescent dyes like SYBR Green, which intercalates with double-stranded DNA to provide non-specific detection, or probe-based systems such as , where a fluorophore-quencher-labeled enables specific identification via during extension, yielding cycle threshold (Ct) values that inversely correlate with initial template abundance. In diagnostics, RT-PCR excels at detection, as exemplified by its widespread use in quantifying SARS-CoV-2 RNA in clinical samples during the , where assays targeting the viral nucleocapsid or spike genes achieve high sensitivity for early infection diagnosis. Additionally, RT-PCR facilitates studies of by amplifying and distinguishing splice variants through isoform-specific primers, revealing regulatory mechanisms in . RT-PCR offers high , capable of detecting low-abundance transcripts down to single-molecule levels in optimized assays, making it invaluable for analyzing rare RNAs in limited samples. However, its reliance on RNA substrates introduces risks from RNase , which can degrade templates and lead to false negatives, necessitating rigorous RNase-free protocols and inhibitors. For relative quantification in RT-qPCR, the Livak (also known as the 2^{-\Delta\Delta C_t} ) is widely used to normalize target expression against a and sample. The calculates fold change as $2^{-\Delta\Delta C_t}, where \Delta C_t = C_{t,\text{target}} - C_{t,\text{reference}} represents the in Ct values between the target and s, and \Delta\Delta C_t is the between \Delta C_t values of the sample and calibrator. This assumes near-100% PCR efficiency for both amplicons and provides a straightforward measure of relative expression changes. Unlike standard PCR, which amplifies directly from DNA templates, RT-PCR addresses RNA instability by incorporating a dedicated reverse transcription step with enzymes like MMLV reverse transcriptase, which lacks RNase H activity in engineered variants to preserve RNA templates during cDNA synthesis, enabling reliable analysis of transient RNA populations.

Error-Prone PCR

Error-prone PCR is a variant of the standard polymerase chain reaction (PCR) intentionally designed to incorporate random mutations into amplified DNA sequences, thereby generating diverse genetic libraries for directed evolution studies. Unlike conventional PCR, which aims for high-fidelity amplification, error-prone PCR exploits the inherent error rate of DNA polymerases under suboptimal conditions to introduce point mutations, insertions, and deletions at controllable frequencies. This technique emerged in the early 1990s as a key tool in protein engineering, with the foundational method described by Cadwell and Joyce in 1992, who demonstrated randomization of genes through biased PCR conditions using Taq polymerase. The development of error-prone PCR in the 1990s facilitated breakthroughs in , notably by Frances H. Arnold, who applied it to evolve enzymes such as subtilisin E for enhanced and activity in organic solvents, achieving up to 100-fold improvements in targeted properties through iterative rounds of and screening. Similarly, Greg Winter and colleagues utilized error-prone for , enabling affinity maturation of human antibody fragments displayed on phage, which increased binding affinities by orders of magnitude for therapeutic applications. These early applications underscored the method's utility in mimicking natural evolution to optimize protein function. Mutations in error-prone PCR primarily consist of transitions and transversions, with occasional insertions or deletions arising from polymerase slippage, resulting in a spectrum that can be biased toward specific nucleotide changes depending on reaction parameters. The mutation rate is tunable, typically achieving 1–5 mutations per kilobase, by adjusting factors such as the number of PCR cycles (often 20–30), which amplifies cumulative errors since each cycle introduces base-pairing mistakes at a low rate (e.g., 10^{-4} to 10^{-3} per base per cycle). The overall frequency approximates the product of per-cycle error rate and cycle number, allowing libraries with 10^6–10^9 variants for subsequent selection. Common methods to induce errors include using unbalanced dNTP concentrations (e.g., elevating dGTP and dCTP to favor G-C transitions while limiting dATP and dTTP), incorporating Mn^{2+} ions (0.05–0.5 mM) to chelate Mg^{2+} and destabilize base pairing, employing low-fidelity polymerases like Mutazyme II, or introducing biases in primers to target specific regions. These approaches ensure even distribution of across the while minimizing excessive frameshifts that could inactivate most variants. In applications, error-prone serves as random for optimizing enzymes, such as enhancing the of lipases or proteases for biocatalysis, where variants with improved performance under extreme conditions are screened from libraries. It is also pivotal in maturation, generating scFv or fragments with higher specificity for . Mutant libraries created via error-prone are often combined with recombination techniques like —developed by Stemmer in 1994—to explore larger sequence spaces by reassembling beneficial mutations, amplifying diversity beyond simple point changes and yielding synergistic improvements in protein properties.

Chemical DNA Synthesis

Oligonucleotide Synthesis

Oligonucleotide synthesis refers to the chemical production of short, single-stranded DNA fragments, typically ranging from 10 to 200 nucleotides in length, using solid-phase phosphoramidite chemistry without the need for templates or enzymes. This method, pioneered in the early 1980s, enables the automated assembly of custom DNA sequences essential for applications in molecular biology, such as probes and primers. The process builds oligonucleotides in the 3' to 5' direction on a solid support, allowing for iterative addition of protected nucleoside monomers. The standard phosphoramidite approach involves four cyclic steps performed on an automated . First, deprotection removes the 5'-dimethoxytrityl (DMT) from the growing chain using an acid, such as 3% in , exposing the 5'-hydroxyl for the next addition. Second, introduces a protected monomer (for , , , or ) activated by , forming a phosphite triester linkage with approximately 98-99% per step. Third, capping acetylates any unreacted 5'-hydroxyl groups using and N-methylimidazole to prevent further extension of failure sequences. Finally, oxidation converts the unstable phosphite triester to a stable phosphate triester using iodine in water or . These cycles repeat until the desired length is achieved, after which the is cleaved from the support (e.g., controlled-pore glass beads) and deprotected under basic conditions. Nucleoside phosphoramidites serve as the key building blocks, featuring β-cyanoethyl-protected phosphates and base-specific protecting groups (e.g., benzoyl for and , isobutyryl for ) to ensure selective reactivity. The overall crude for a 50-mer is approximately 37% when assuming a 98% per step, calculated as: \text{[Yield](/page/Yield)} = (0.98)^n where n is the number of added. This exponential decay highlights the method's sensitivity to stepwise . Post-synthesis purification typically employs reverse-phase (HPLC) or (PAGE) to isolate full-length products from truncated failures. Modified oligonucleotides, such as those conjugated with for affinity capture or fluorophores for detection, are readily synthesized by incorporating functionalized phosphoramidites during assembly. Despite its efficiency, phosphoramidite synthesis has limitations, including cumulative error rates from incomplete couplings and side reactions like , which predominantly result in deletions and restrict practical lengths to around 100 . Costs range from $0.10 to $0.50 per base, depending on scale and modifications, making it economical for short sequences but less viable for longer constructs.

Gene Synthesis and Assembly

Gene synthesis and assembly involves the hierarchical construction of long DNA sequences, typically exceeding 1 kb, from shorter synthetic oligonucleotides to produce custom genes de novo. This process enables the creation of novel genetic constructs without relying on natural templates, facilitating precise engineering for various biological applications. The field originated with the pioneering work of Har Gobind Khorana's group, who in 1977 achieved the total chemical synthesis of a functional tyrosine suppressor tRNA gene, marking the first de novo assembly of a biologically active gene through ligation of chemically synthesized oligonucleotides.50484-1/fulltext) This breakthrough laid the foundation for modern techniques, which evolved in the with the advent of high-throughput commercial services, such as those pioneered by GeneArt starting in 2000, enabling scalable production of synthetic genes through automated assembly pipelines. Several enzymatic methods have been developed to assemble overlapping into full-length genes, improving efficiency and reducing errors compared to early ligation-based approaches. Overlap extension , introduced in 1989, utilizes thermocycling to anneal and extend overlapping , allowing iterative assembly of gene fragments into complete sequences. , described in 2009, performs isothermal joining in a single reaction through the coordinated action of a 5' for end resection, a for gap filling, and a for sealing nicks, accommodating up to several hundred kilobases with 20-40 overlaps for optimal efficiency. assembly, developed in 2008, employs type IIS restriction enzymes that cut outside their recognition sites to enable scarless, directional ligation of multiple fragments in a one-pot reaction, minimizing unwanted recombinations and supporting modular designs. Assembly efficiency in these methods generally increases with overlap lengths of 20-40 , balancing specificity and yield. Gene design for synthesis prioritizes features that enhance expression and compatibility with assembly methods, such as codon optimization to match host organism preferences, thereby improving translation efficiency without altering the protein sequence. Sequences are also engineered to avoid unwanted restriction sites that could interfere with or , particularly in methods like . Error correction is integral, as chemical introduces at rates of 1 in 100-300 bases; post-assembly strategies include selective hybridization to biotinylated probes for enriching correct sequences or high-throughput sequencing to verify and select error-free clones.00237-2) Applications of gene synthesis span and , exemplified by the 2010 assembly of a 1.08 Mb synthetic for mycoides by Venter's team, which was transplanted into a recipient cell to create the first self-replicating synthetic bacterium, demonstrating the potential for genome-scale engineering. In development, synthetic genes serve as templates for transcription of mRNA encoding antigens, as seen in the rapid design and production of SARS-CoV-2 genes for vaccines. benefits from custom gene synthesis to introduce or optimize pathways, such as assembling genes in for production. Current capabilities support of genes up to 50-100 , with commercial providers offering sequence-verified constructs delivered in weeks. Costs have declined to approximately $0.07-0.20 per as of 2025, driven by high-throughput production via printing followed by automated . This scalability enables widespread use in research and industry, though longer assemblies require iterative hierarchical strategies to maintain fidelity.

References

  1. [1]
    DNA Replication - National Human Genome Research Institute
    DNA replication is the process by which the genome's DNA is copied in cells. Before a cell divides, it must first copy (or replicate) its entire genome.
  2. [2]
    DNA Synthesis - The CSUDH
    There are four basic components required to initiate and propagate DNA synthesis. They are: substrates, template, primer and enzymes.
  3. [3]
    Synthetic DNA Synthesis and Assembly - PubMed Central - NIH
    The synthesis of synthetic DNA is often referred to generically as “gene synthesis,” which specifically is the synthesis of gene-length pieces of DNA (250–2000 ...
  4. [4]
    DNA synthesis technologies to close the gene writing gap - Nature
    Jan 23, 2023 · The ability to sequentially synthesize polynucleotides, nucleotide by nucleotide, allows for control over the composition and size of DNA.
  5. [5]
    DNA Replication - The Cell - NCBI Bookshelf - NIH
    Helicase, primase, and two molecules of DNA polymerase III carry out coordinated synthesis of both the leading and lagging strands of DNA. The lagging strand ...
  6. [6]
    The Initiation and Completion of DNA Replication in Chromosomes
    The different replication origins in these eucaryotic chromosomes are activated in a sequence, determined in part by the structure of the chromatin, with the ...Missing: eukaryotes | Show results with:eukaryotes
  7. [7]
    Telomere Replication: Solving Multiple End Replication Problems
    In most eukaryotes, this problem is solved by 3′ extension of telomeres by a reverse transcriptase called telomerase, and subsequent fill in by conventional DNA ...
  8. [8]
    Ribonuclease H: Properties, Substrate Specificity, and Roles ... - NIH
    The RNase H activity of reverse transcriptase is required for several stages of the reverse transcription process (reviewed in [4,6,7]), making it an essential ...
  9. [9]
    HIV-1 Reverse Transcription - PMC - PubMed Central
    Retroviruses package two copies of the viral RNA genome; the first (or minus-strand) transfer can involve the R sequence at the 3′ ends of either of the two ...
  10. [10]
    Reverse Transcriptase Properties | Thermo Fisher Scientific - US
    The RNase H activity is undesirable for synthesis of long cDNAs because the RNA template may be degraded before completion of full-length reverse transcription.DNA polymerase activity · RNase H activity · Thermostability · Processivity
  11. [11]
    DNA EXCISION REPAIR - Annual Reviews
    Jul 1, 1996 · In nucleotide excision repair DNA damage is removed through incision of the damaged strand on both sides of the lesion, followed by repair synthesis.
  12. [12]
    Early steps in the DNA base excision/single-strand interruption ...
    Jan 1, 2008 · BER involves 4-5 steps starting with base excision by a DNA glycosylase, followed by a common pathway usually involving an AP-endonuclease (APE) to generate 3′ ...
  13. [13]
    Long-patch DNA repair synthesis during base excision repair in ...
    The mean patch length is 2–6 nucleotides for the 8-oxoG damage and 6–12 nucleotides for the synthetic AP site. Consequently, the lesion, and not the mismatch ...
  14. [14]
    Characterization of long patch excision repair of DNA in ultraviolet ...
    Approximately 99% of the repair events result in short patches of 20–30 nucleotides produced by a constitutive repair system. The remaining 1% result in patches ...<|separator|>
  15. [15]
    Eukaryotic nucleotide excision repair: from understanding ... - Nature
    Repair of bulky DNA adducts by the nucleotide excision repair (NER) pathway is one of the more versatile DNA repair pathways for the removal of DNA lesions.
  16. [16]
    Mechanisms and functions of DNA mismatch repair | Cell Research
    Dec 24, 2007 · DNA mismatch repair (MMR) is a highly conserved biological pathway that plays a key role in maintaining genomic stability.
  17. [17]
    MISMATCH REPAIR IN REPLICATION FIDELITY, GENETIC ...
    Jul 1, 1996 · Mismatch repair stabilizes the cellular genome by correcting DNA replication errors and by blocking recombination events between divergent DNA sequences.
  18. [18]
    Kary B. Mullis – Facts - NobelPrize.org
    In 1985, Kary Mullis invented the process known as polymerase chain reaction (PCR), in which a small amount of DNA can be copied in large quantities over a ...
  19. [19]
    Deoxyribonucleic acid polymerase from the extreme thermophile ...
    7.7) with a temperature optimum of 80 degrees C has been purified from the extreme thermophile Thermus aquaticus. The enzyme is free from phosphomonoesterase, ...
  20. [20]
    Polymerase chain reaction (PCR) (article) - Khan Academy
    The key ingredients of a PCR reaction are Taq polymerase, primers, template DNA, and nucleotides (DNA building blocks). The ingredients are assembled in a tube, ...
  21. [21]
    PCR Basics | Thermo Fisher Scientific - US
    Three steps of PCR─denaturation, annealing, and extension─as shown in the first cycle, and the exponential amplification of target DNA with repeated cycling.
  22. [22]
    Mathematics of quantitative kinetic PCR and the application of ... - NIH
    Mathematics of quantitative kPCR. The basic equation describing PCR amplification is: NC = N0·(E + 1)C1. where C is the number of thermocycles, E is ...
  23. [23]
    PCR in Forensic Science: A Critical Review - PMC - NIH
    Mar 29, 2024 · This review examines the evolution of the PCR from its inception in the 1980s, through to its current application in forensic science.
  24. [24]
    How is Hot-Start Technology Beneficial For Your PCR
    Hot-start modifications inhibit DNA polymerase's activity at room temperature, preventing spurious bands from nonspecific amplification.Missing: limitations | Show results with:limitations
  25. [25]
  26. [26]
    Error Rate Comparison during Polymerase Chain Reaction by DNA ...
    Given the amplification efficiency of each PCR reaction, the error rate (average of 2 experiments) for Taq polymerase is 4.3 × 10−5 ± 1.8 mutations/bp per ...
  27. [27]
    50th anniversary of the discovery of reverse transcriptase - PMC
    Jan 15, 2021 · The simultaneous discovery in 1970 of reverse transcriptase in virions of retroviruses by Howard Temin and David Baltimore was perhaps the most dramatic ...Introduction · Madison, 1960--1969 · Madison, 1970
  28. [28]
  29. [29]
    One-Step vs Two-Step RT-PCR | Thermo Fisher Scientific - US
    RT-PCR can be performed in a one-step or a two-step assay. One-step assays combine reverse transcription and PCR in a single tube and buffer.
  30. [30]
    M-MLV Reverse Transcriptase - Promega Corporation
    M-MLV RT is an RNA-dependent DNA polymerase that can be used in cDNA synthesis with long messenger RNA templates (>5kb).
  31. [31]
    Analysis of One-Step and Two-Step Real-Time RT-PCR Using ... - NIH
    The main advantage to two-step RT-PCR is that typically random hexamer or oligo dT primers are used in an RT reaction in a separate tube. ... random hexamers and ...
  32. [32]
  33. [33]
    Methods for Characterization of Alternative RNA Splicing - PMC - NIH
    Quantification of alternative splicing to detect the abundance of differentially spliced isoforms of a gene in total RNA can be accomplished via RT-PCR.
  34. [34]
    Minimizing errors in RT-PCR detection and quantification of SARS ...
    Such a high sensitivity is particularly useful for SARS-CoV-2 surveillance in wastewater where the RNA target concentration can be extremely low (Ahmed et al., ...<|control11|><|separator|>
  35. [35]
    Analysis of relative gene expression data using real-time ... - PubMed
    The 2(-Delta Delta C(T)) method is a convenient way to analyze the relative changes in gene expression from real-time quantitative PCR experiments.
  36. [36]
    M-MuLV reverse transcriptase: Selected properties and improved ...
    Nov 22, 2021 · This review will give a brief description of the structure, thermal stability, processivity, and fidelity, focusing on improving M-MuLV RT for practical usage.
  37. [37]
    A primer to directed evolution: current methodologies and future ...
    Jan 27, 2023 · (b) In error-prone PCR, random mutations are introduced by a low fidelity polymerase, resulting in linear DNA fragments with point mutations, ...
  38. [38]
    Deoxyoligonucleotide synthesis via the phosphoramidite method
    Deoxyoligonucleotide synthesis via the phosphoramidite method. Gene Amplif Anal. 1983:3:1-26. Authors. M H Caruthers , S L Beaucage, C Becker, J W Efcavitch ...Missing: DNA | Show results with:DNA
  39. [39]
  40. [40]
    Technical Brief – Synthesis of Long Oligonucleotides - Glen Research
    While an average coupling efficiency of 98.0% would theoretically yield 68% full-length product for a 20mer, it would only yield 13% full-length product for a ...
  41. [41]
    The gene makers - SCI – Where Science Meets Business
    GeneArt in Germany, the world's largest manufacturer of genes, has seen its production capacity double each year since it entered the market in 2000. 'The gene ...
  42. [42]
    Site-directed mutagenesis by overlap extension using the ...
    Apr 15, 1989 · Overlap extension represents a new approach to genetic engineering. Complementary oligodeoxyribo-nucleotide (oligo) primers and the polymerase chain reaction ...
  43. [43]
    Enzymatic assembly of DNA molecules up to several hundred ...
    Apr 12, 2009 · We describe an isothermal, single-reaction method for assembling multiple overlapping DNA molecules by the concerted action of a 5′ exonuclease, a DNA ...
  44. [44]
  45. [45]
    Gibson Assembly 101: Expert Cloning Tips You Need to Know
    May 29, 2025 · The proper overlap length for Gibson Assembly typically ranges from 20 to 40 base pairs. This length is sufficient to ensure that the fragments ...What is Gibson assembly? · Gibson Assembly protocol · Gibson Assembly...
  46. [46]
    Creation of a Bacterial Cell Controlled by a Chemically Synthesized ...
    May 20, 2010 · We report the design, synthesis, and assembly of the 1.08–mega–base pair Mycoplasma mycoides JCVI-syn1.0 genome starting from digitized genome sequence ...
  47. [47]
    mRNA vaccines for infectious diseases: principles, delivery ... - Nature
    Aug 25, 2021 · Principles of mRNA design and synthesis. mRNA vaccines comprise synthetic mRNA molecules that direct the production of the antigen that will ...
  48. [48]
    2025 Pricing Announcement - Elegen
    Elegen now ships US-made, cell-free, ENFINIA™ standard complexity linear DNA as low as $0.15 / base pair and high-complexity plasmids from $0.20/ base pair.
  49. [49]
    Genes Overview | Twist Bioscience
    From 7¢ (USD) per base pair*. ok, 2 - 4 ... We make use of Twist Bioscience's high success rate and fast turnover times of gene synthesis and custom cloning.